Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Extracellular signal-regulated kinase 8 (ERK8), also known as MAPK15, is a member of the mitogen-activated protein kinase (MAPK) family. It plays diverse roles in cellular processes, including cell adhesion, cell cycle control, and apoptosis. ERK8 uniquely interacts with nuclear receptors like ERRα, acting as a corepressor. It's implicated in protecting genomic integrity, regulating glycosylation, and influences organelle dynamics. Aberrant ERK8 function has been linked to cancers such as breast and colon cancer, suggesting a complex role as both an oncogene and tumor suppressor depending on the cellular context. Its unique structural features offer opportunities for selective small-molecule inhibitor development.
Kinase inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular signal-regulated kinase 8 (ERK8).